SCHEMBL22563537

SCHEMBL22563537

N#Cc1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C#N)cc4C#N)ccc2n3-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)c(-n3c4ccc(-c5ccc(C#N)cc5C#N)cc4c4cc(-c5ccc(C#N)cc5C#N)ccc43)cc2C#N)c(C#N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.37
JAK2 O60674 1/20 0.37
PRKD3 O94806 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
LCK P06239 1/20 0.37
CDK1 P06493 1/20 0.37
CSF1R P07333 1/20 0.37
LYN P07948 1/20 0.37
RET P07949 1/20 0.37
KIT P10721 1/20 0.37
FGFR1 P11362 1/20 0.37
FER P16591 1/20 0.37
FLT1 P17948 1/20 0.37
FGFR3 P22607 1/20 0.37
KDR P35968 1/20 0.37
FLT3 P36888 1/20 0.37
FRK P42685 1/20 0.37
SYK P43405 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23487697 0.98 CSNK2A1 (0.36) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL21279060 0.94 ABCG2 (0.39) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL22563381 0.94 ABCG2 (0.37) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL22268547 0.94 ABCG2 (0.37) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL23487301 0.93 PTGER4 (0.36) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL22268541 0.93 PTGER4 (0.36) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL19943185 0.93 CYP1A2 (0.36) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL19909092 0.92 MYC (0.39) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL22563702 0.92 ABCG2 (0.40) CSNK2A1JAK2PRKD3ABL1EGFR
SCHEMBL21108059 0.91 PTGER4 (0.36) CLK4ABCG2ABCB1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 CSNK2A1 2546/4885JAK2 2511/4885PRKD3 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.